Ventilatory Management of the Preterm Neonate in the Delivery Room
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01255826|
Recruitment Status : Completed
First Posted : December 8, 2010
Last Update Posted : August 31, 2017
|Condition or disease||Intervention/treatment||Phase|
|Respiratory Distress Syndrome, Newborn||Procedure: Resuscitation of preterm neonates by sustained lung inflation through T piece device followed by CPAP Procedure: Resuscitation of preterm neonates by intermittent bag and mask ventilation using self inflating bag.||Phase 2|
Neonatal resuscitation provides lifesaving intervention that, if properly conducted, not only can reduce mortality but probably can significantly decrease subsequent morbidity.
Premature infants need appropriate respiratory support and a lung-protective strategy, starting from the delivery room where, on the contrary, an inadequate respiratory approach may influence pulmonary outcome.
Mechanical ventilation in the form of positive pressure ventilation has remained the mainstay of treatment of respiratory distress syndrome (RDS) in preterm babies. In recent years, a number of new ventilation strategies have been introduced but the problem of bronchopulmonary dysplasia (BPD) has not been solved.
Sustained lung inflation (SLI) lead to a large increase in the tidal volume and the functional residual capacity(FCR) as this intervention may influence the clearance of lung fluids and allow a more even distribution of air throughout the lungs, thus facilitating the formation of FRC.
Nasal CPAP and early PEEP act through stabilization and subsequent recruitment of collapsed alveoli, increased FRC resulting in increased alveolar surface area for gas exchange and a decrease in intrapulmonary shunt .also it conserves endogenous surfactant.
Previous studies with promising results showed that a combination of sustained lung inflation and early nasal CPAP may be the most effective and least injurious way to recruit the lung in preterm neonates at birth.
This study will evaluate sustained lung inflation followed by early nCPAP as delivery room ventilatory management for preterm neonates at risk of respiratory distress syndrome in reducing their need for mechanical ventilation and ameliorating lung injury without inducing adverse effects compared with intermittent bag and mask ventilation.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||112 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Ventilatory Management of the Preterm Neonate in the Delivery Room.|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||December 2013|
Active Comparator: Sustained lung inflation followed by CPAP
Sustained pressure-controlled inflation using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher & Paykel, Auckland, New Zealand).
This will be followed by early CPAP.
Procedure: Resuscitation of preterm neonates by sustained lung inflation through T piece device followed by CPAP
After oropharyngeal and nasal suctioning, if there are no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, the following approach will be followed:Pressure-controlled (20 cm H2O) inflation will be sustained for 15 secs, using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher & Paykel).To avoid pressure leakage, we will use a neonatal mask of appropriate size which adequately cover both the mouth and nostrils of infants. This pressure controlled inflation will be followed by CPAP at 5 Cm H2O.This procedure will be repeated a second time with a pressure of 25 cm H2O for 15 secs if breathing remained insufficient and/or the heart rate is < 100 bpm and/or the infant is cyanotic. To be followed by CPAP at 6 Cm H2O.A third puff with a pressure of 30 cm H2O for 15 secs will be used after few seconds if inadequate heart rate and respiration was not reached. This will be followed by CPAP at 7 Cm H2O.
Active Comparator: Conventional self inflating bag and mask ventilation
Intermittent bag and mask ventilation using a self-inflating bag with an oxygen reservoir.
Procedure: Resuscitation of preterm neonates by intermittent bag and mask ventilation using self inflating bag.
After oropharyngeal and nasal suctioning, if there is no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, intermittent mask and bag ventilation will be administrated at a rate 40-60 per minute using a self-inflating bag and mask with an oxygen reservoir.
- Proportionate of neonates in each group who will need endotracheal intubation after failure of positive pressure ventilation through face mask in the delivery room. [ Time Frame: 2 minutes ]
- Need for mechanical ventilation for neonates on nCPAP [ Time Frame: 28 days ]
- Occurrence and duration of oxygen therapy. [ Time Frame: 28 days ]
- Bronchopulmonary dysplasia (BPD): defined as oxygen requirements more than 28 days. [ Time Frame: 28 days ]
- Pulmonary air leaks [ Time Frame: 28 days ]
- Patent ductus arteriosus (PDA). [ Time Frame: 7 days ]
- Necrotizing enterocolitis (NEC). [ Time Frame: 28 days ]
- Intraventricular hemorrhage (IVH). [ Time Frame: 28 days ]
- Neonatal sepsis. [ Time Frame: 28 days ]
- Length of NICU stay. [ Time Frame: 28 days ]
- Delivery room death or death during admission. [ Time Frame: 28 days ]
- Inflammatory mediators before and after resuscitation [ Time Frame: 2 hours ]Serum Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α)will be measured both initial cord blood before any resuscitation is done and a second time two hours after resuscitation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255826
|Gynecology and Obstetrics hospital, Ain-Shams University|
|Principal Investigator:||Mohamed Sami El Shimi, MD||Ain Shams University|
|Principal Investigator:||Hesham Abdel Samie Awad, MD||Ain Shams University|
|Principal Investigator:||Tarek Mohey El Gammacy, MD||Ain Shams University|
|Principal Investigator:||Ola Galal Badr El Deen, MD||Ain Shams University|
|Principal Investigator:||Dina Mohamed Mohamed Shinkar, MSc||Ain Shams University|